We are live on ! Find out more
NXTC icon

NextCure
NXTC

44 hedge funds and large institutions have $18.4M invested in NextCure in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.66% less ownership

Funds ownership: 4.58% → 3.92% (-0.66%)

15% less funds holding

Funds holding: 52 → 44 (-8)

40% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 15

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

56% less capital invested

Capital invested by funds: $41.8M → $18.4M (-$23.4M)

Holders
44
Holders Change
-8
Holders Change %
-15.38%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
15
Closed
13
Calls
$156K
Puts
–
Net Calls
+$156K
Net Calls Change
-$269K

Top Buyers

Rank Fund Capital Flow
1
CPA
Cardiff Park Advisors
California
+$502K
2
Renaissance Technologies
Renaissance Technologies
New York
+$339K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$249K
4
Millennium Management
Millennium Management
New York
+$233K
5
BCM
Bridgeway Capital Management
Texas
+$172K

Top Sellers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
-$4.19M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$617K
3
BlackRock
BlackRock
New York
-$384K
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$264K
5
Federated Hermes
Federated Hermes
Pennsylvania
-$261K

NXTC Hedge Fund Activity: Q4 2022 in Review

44 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2022, worth a combined $18.4M — down 56% from $41.8M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of NXTC and 6 opened new positions — a net loss of 7 holders — while 15 trimmed existing stakes and 9 added.

The largest buyer was Cardiff Park Advisors, opening a new position worth an estimated $502K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $4.19M sold.

  • 44 institutional investors held NextCure (NXTC) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $18.4M of NextCure stock for Q4 2022, down 56% quarter-over-quarter.
  • 6 funds opened new NextCure positions in Q4 2022 and 13 closed out, a net change of -7 holders.
  • The largest NextCure buyer in Q4 2022 was Cardiff Park Advisors, an estimated $502K added.
  • The largest NextCure seller in Q4 2022 was K2 Principal Fund, an estimated $4.19M sold.

Based on aggregated 13F filings for Q4 2022.